This information is not medical advice and is not a substitute for diagnosis or treatment by a physician.Data sources and disclaimers (data limitations, copyright, etc.)The analysis on "Side Effects of betrixaban: A Synthesis of Findings from 1 Studies" on this page is based on PubMed data provided by the U.S. National Library of Medicine (NLM). However, NLM does not endorse or verify these analyses.

This analysis is based on research papers included in PubMed, but medical research is constantly evolving and may not fully reflect the latest findings. There may also be biases towards certain research areas.

This information is not medical advice and is not a substitute for diagnosis or treatment by a physician. If you have concerns about "Side Effects of betrixaban: A Synthesis of Findings from 1 Studies", please consult your doctor.

For NLM copyright information, please see Link to NLM Copyright Page
PubMed data is obtained via Hugging Face Datasets: Link to Dataset
Please check the disclaimer.
This page's analysis is based on PubMed data provided by the U.S. National Library of Medicine (NLM).
Original Abstract of the Article

Main Research Findings

New oral anticoagulants (NOACs) have emerged as a more effective and safer alternative to traditional vitamin K antagonists (warfarin or acenocumarol). 1 They work differently, don't require constant monitoring, and are considered more effective and safer than vitamin K antagonists. 1 The use of these molecules (Dabigatran, Apixaban, Rivaroxaban, Betrixaban, Edoxaban) is continuously increasing in everyday practice. 1 However, while available data suggest NOAC/DOAC use is safe, dosage adjustments are needed based on kidney or liver function. 1 It's important to note that commonly used blood tests [Prothrombin Time (PT) and partial thromboplastin time (PTT)] are not suitable for monitoring the anticoagulant activity of these compounds. 1 With the exception of dabigatran, we currently lack a specific antidote to reverse the anticoagulant effect of NOAC/DOAC. 1 This article reviews available evidence on NOAC/DOAC pharmacokinetics, risk factors for bleeding, interventions to reverse anticoagulant activity in case of hemorrhages or need for urgent surgery, and/or NOAC/DOAC overdose or side effects. 1

Reasons for Side Effects

NOACs work by inhibiting blood clotting factors. 1 This can increase the risk of bleeding. 1 Additionally, NOACs are metabolized by the kidneys, and if kidney function is impaired, they can accumulate in the body, leading to a higher risk of bleeding. 1 NOACs are also metabolized by the liver, so impaired liver function can also increase the risk of side effects. 1

Common Side Effects

Bleeding

The most common side effect of NOACs is bleeding. 1 Bleeding can occur in the digestive system, brain, or other organs. 1

Gastrointestinal Side Effects

NOACs can cause gastrointestinal side effects. 1 These include stomach pain, diarrhea, and constipation. 1

Liver Side Effects

NOACs can cause liver side effects. 1 These include abnormalities in liver function. 1

Kidney Side Effects

NOACs can cause kidney side effects. 1 These include abnormalities in kidney function. 1

Managing Side Effects

Bleeding

If bleeding occurs, seek immediate medical attention. 1 If the bleeding is severe, treatment such as blood transfusions may be necessary. 1 Idarucizumab can be used to reverse the anticoagulant effects of dabigatran. 1 There is no effective antidote for other NOACs. 1

Gastrointestinal Side Effects

If gastrointestinal side effects occur, consult a doctor. 1 You may need to change medications or implement dietary changes. 1

Liver Side Effects

If liver side effects occur, consult a doctor. 1 You may need to change medications or undergo treatment aimed at improving liver function. 1

Kidney Side Effects

If kidney side effects occur, consult a doctor. 1 You may need to change medications or undergo treatment aimed at improving kidney function. 1

Comparison Between Studies

Commonalities

This article discusses various studies on the safety and efficacy of NOACs. 1 These studies suggest that NOACs are a more effective and safe alternative to traditional vitamin K antagonists. 1

Differences

Research findings may vary depending on the type of NOAC and the disease being treated. 1 For example, the risk of bleeding and the frequency of side effects may differ depending on the NOAC used. 1

Implications for Real-Life Applications

NOACs are considered a more effective and safer alternative to traditional vitamin K antagonists. 1 However, dosage adjustments are needed based on kidney or liver function. 1 Additionally, NOACs carry a higher risk of bleeding. 1 When using NOACs, follow your doctor's instructions carefully and attend regular check-ups. 1

Limitations of Current Research

There is still insufficient research on NOACs. 1 Further research is needed, especially on the long-term safety and effectiveness of NOACs. 1 Developing specific antidotes to reverse the anticoagulant effects of NOACs is also a crucial challenge. 1

Future Research Directions

Further research is needed on the long-term safety and effectiveness of NOACs, the development of specific antidotes to reverse the anticoagulant effects of NOACs, and the individual variability in response to NOACs. 1

Conclusion

NOACs are considered a more effective and safe alternative to traditional vitamin K antagonists. 1 However, they have a higher risk of bleeding. 1 When using NOACs, follow your doctor's instructions carefully and attend regular check-ups. 1


Literature analysis of 1 papers
Positive Content
1
Neutral Content
0
Negative Content
0
Article Type
0
0
0
1
1

Language : Italian


This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.